Target intelligence / Profile preview

Pathogenic bacterium in urogenital tract

Molecular classification
Other
01

Overview

"Pathogenic bacteria in urogenital tract" is not a single molecular target, receptor, or protein, but rather an umbrella term that encompasses multiple bacterial species capable of infecting the urinary and genital tracts. These pathogens include but are not limited to Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Staphylococcus saprophyticus, Enterococcus faecalis, and sexually transmitted bacteria such as Chlamydia trachomatis and Neisseria gonorrhoeae[3][4][5][1][2]. These bacteria colonize or invade the urothelial lining, can form biofilms, cause inflammation, and are responsible for various clinical syndromes such as urinary tract infection (UTI), cystitis, pyelonephritis, prostatitis, urethritis, vaginitis, and pelvic inflammatory disease[1][2][3][4][5][6]. The molecular mechanisms vary by pathogen, often involving adhesins, pili, toxins, and mechanisms of immune evasion[4]. Disease management typically involves antibiotics, but antibiotic resistance and recurrent infections are major clinical concerns[3][4][5].\n\nImportant note:\nThe queried term “Pathogenic bacteria in urogenital tract” is not a specific, singular target (such as a protein, receptor, or enzyme), but rather a broad category that refers to various disease-causing bacterial species. It does not conform to the typical target molecule/receptor requested in your data structure, so it should be flagged as an incorrect or non-specific target for structured curation[3][5].

Other names
Pathogenic bacteria of the urogenital tractUropathogenUrogenital bacterial pathogenGenitourinary pathogens
02

Mechanism of action

Inhibition of cell wall synthesis; Inhibition of bacterial protein synthesis; Inhibition of DNA replication; Inhibition of folate synthesis

03

Biological functions

InfectionColonization of urogenital epitheliumImmune evasion
04

Disease associations

InfectionOther (urinary tract infection, genitourinary tract infection, sexually transmitted infection)
05

Safety considerations

Antibiotic resistance (multi-drug resistant strains)Risk of recurrenceDisruption of normal microbiotaAllergic reactions to antibiotics
06

Interacting drugs

Amoxicillin

8 more in the full profile.

07

Biomarkers

Colony count (CFU/mL) in urine cultureLeukocyte esterase in urineNitrites in urine

Beyond the preview

Go deeper on Pathogenic bacterium in urogenital tract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic bacterium in urogenital tract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call